CDYL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.08186809405697E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.00410000003492E-06 |
Normal-vs-Stage2 |
5.97050000550325E-08 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
6.26220186816795E-11 |
Stage1-vs-Stage2 |
4.754400E-02 |
Stage1-vs-Stage3 |
2.57650000001775E-07 |
Stage1-vs-Stage4 |
1.641630E-03 |
Stage2-vs-Stage3 |
2.072200E-01 |
Stage2-vs-Stage4 |
5.199200E-01 |
Stage3-vs-Stage4 |
5.307000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.66378022470326E-12 |
Normal-vs-AfricanAmerican |
1.061840E-02 |
Normal-vs-Asian |
6.479900E-02 |
Caucasian-vs-AfricanAmerican |
8.769700E-02 |
Caucasian-vs-Asian |
4.510400E-01 |
AfricanAmerican-vs-Asian |
8.665800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.91158241750145E-12 |
Normal-vs-Female |
1.48500001184715E-09 |
Male-vs-Female |
5.225200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.55100000000164E-05 |
Normal-vs-Age(41-60Yrs) |
7.39190000320633E-08 |
Normal-vs-Age(61-80Yrs) |
1.82787118774286E-12 |
Normal-vs-Age(81-100Yrs) |
7.79269999640064E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.013600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.380000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.251800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.089700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.213900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.568200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.127000E-01 |
Normal-vs-Grade 2 |
1.76609999957833E-08 |
Normal-vs-Grade 3 |
1.62470037423645E-12 |
Normal-vs-Grade 4 |
5.92830229351193E-11 |
Grade 1-vs-Grade 2 |
1.173030E-01 |
Grade 1-vs-Grade 3 |
4.362300E-02 |
Grade 1-vs-Grade 4 |
3.323800E-02 |
Grade 2-vs-Grade 3 |
3.432000E-04 |
Grade 2-vs-Grade 4 |
1.642090E-03 |
Grade 3-vs-Grade 4 |
4.463400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.78880252224667E-11 |
Normal-vs-ccB subtype |
4.98829999528994E-08 |
ccA subtype-vs-ccB subtype |
9.176000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.87769841078989E-11 |
Normal-vs-N1 |
1.236280E-04 |
N0-vs-N1 |
3.676200E-01 |
|
|